AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Skye Bioscience, Inc. Director's Dealing 2026

Feb 10, 2026

Director's Dealing

Opens in your device viewer

Issuer: Skye Bioscience, Inc. (SKYE)
CIK: 0001516551
Period of Report: 2026-02-06

Reporting Person: Arora Puneet S. (Chief Medical Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-06	Stock Option (Right to Buy)	$0.82	A	125000	Acquired	2036-02-06	Common Stock (125000)	Direct

F1: The stock option vests in equal monthly installments over the four-year period beginning January 19, 2026.